Insulet's Welcome Program for Animas ® Users Now Includes Optional Dexcom G5 ® Mobile CGM Upgrade BILLERICA, Mass --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation's (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is offering the Omnipod ® Welcome Program for existing Animas ® insulin pump users as
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2017 on November 2, 2017
$100 Million Investment in Massachusetts Will Provide for Hundreds of Local Manufacturing Jobs at a 350,000 Square-Foot Facility BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
Data Demonstrate Use of the Omnipod System and Insulet Provided Glooko is Associated with Favorable Mean Blood Glucose Levels Compared to U.S. National Averages BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the appointments of Michael R. Minogue and James C.
Second Quarter Revenue of $109.8 Million , Up 26% Year-Over-Year, Exceeds Expectations; Gross Margin Improves to 58.9% Insulet Raises Full Year 2017 Revenue Guidance to a Range of $440 to $450 million , Up from $425 to $440 Million , Expecting Growth of 21% at Mid-Point BILLERICA, Mass.
Insulet to Host Three Educational Events at the AADE Conference in Indianapolis BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City , New York : This
Direct Distribution Supports Strong and Growing European Customer Base Further Strengthens Company's Financial Outlook BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2017 on August 3, 2017
Strong results show potential for Horizon to improve clinical outcomes in pediatric and adolescent age groups with type 1 diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
Company Further Demonstrates Significant Impact on Improving the Quality of Life of People with Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the William Blair & Co. 37th Annual Growth Stock Conference in Chicago, Illinois on
